Roy Herbst, MD, Yale School of Medicine
Advertisement
Articles by Roy Herbst, MD, Yale School of Medicine
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
INBRX-106 Plus Pembrolizumab Improves Responses and PFS in First-Line PD-L1–Positive HNSCC
2
Five Under 5: Top Oncology Videos for the Week of 9/27
3
FDA Approves Pirtobrutinib for Previously Untreated CLL/SLL
4
NDA Submission Is Initiated for Zipalertinib Plus Chemotherapy in Frontline EGFR Exon 20 Insertion+ NSCLC
5